374 related articles for article (PubMed ID: 36716702)
1. Novel Ionizable Lipid Nanoparticles for SARS-CoV-2 Omicron mRNA Delivery.
Long J; Yu C; Zhang H; Cao Y; Sang Y; Lu H; Zhang Z; Wang X; Wang H; Song G; Yang J; Wang S
Adv Healthc Mater; 2023 May; 12(13):e2202590. PubMed ID: 36716702
[TBL] [Abstract][Full Text] [Related]
2. Chemistry of Lipid Nanoparticles for RNA Delivery.
Eygeris Y; Gupta M; Kim J; Sahay G
Acc Chem Res; 2022 Jan; 55(1):2-12. PubMed ID: 34850635
[TBL] [Abstract][Full Text] [Related]
3. Bivalent mRNA vaccines against three SARS-CoV-2 variants mediated by new ionizable lipid nanoparticles.
Wang J; Zhang Y; Dong S; Zha W; Liu C; Wang Y; Jiang Y; Xing H; Li X
Int J Pharm; 2023 Jul; 642():123155. PubMed ID: 37402442
[TBL] [Abstract][Full Text] [Related]
4. SMART-lipid nanoparticles enabled mRNA vaccine elicits cross-reactive humoral responses against the omicron sub-variants.
Mahalingam G; Rachamalla HK; Arjunan P; Karuppusamy KV; Periyasami Y; Mohan A; Subramaniyam K; M S; Rajendran V; Moorthy M; Varghese GM; Mohankumar KM; Thangavel S; Srivastava A; Marepally S
Mol Ther; 2024 May; 32(5):1284-1297. PubMed ID: 38414245
[TBL] [Abstract][Full Text] [Related]
5. Enzyme-Catalyzed One-Step Synthesis of Ionizable Cationic Lipids for Lipid Nanoparticle-Based mRNA COVID-19 Vaccines.
Li Z; Zhang XQ; Ho W; Li F; Gao M; Bai X; Xu X
ACS Nano; 2022 Nov; 16(11):18936-18950. PubMed ID: 36269150
[TBL] [Abstract][Full Text] [Related]
6. Lipid nanoparticle formulations for optimal RNA-based topical delivery to murine airways.
Tam A; Kulkarni J; An K; Li L; Dorscheid DR; Singhera GK; Bernatchez P; Reid G; Chan K; Witzigmann D; Cullis PR; Sin DD; Lim CJ
Eur J Pharm Sci; 2022 Sep; 176():106234. PubMed ID: 35688311
[TBL] [Abstract][Full Text] [Related]
7. Design of SARS-CoV-2 hFc-Conjugated Receptor-Binding Domain mRNA Vaccine Delivered
Elia U; Ramishetti S; Rosenfeld R; Dammes N; Bar-Haim E; Naidu GS; Makdasi E; Yahalom-Ronen Y; Tamir H; Paran N; Cohen O; Peer D
ACS Nano; 2021 Jun; 15(6):9627-9637. PubMed ID: 33480671
[TBL] [Abstract][Full Text] [Related]
8. mRNA Vaccines Against SARS-CoV-2 Variants Delivered by Lipid Nanoparticles Based on Novel Ionizable Lipids.
Chen K; Fan N; Huang H; Jiang X; Qin S; Xiao W; Zheng Q; Zhang Y; Duan X; Qin Z; Liu Y; Zeng J; Wei Y; Song X
Adv Funct Mater; 2022 Sep; 32(39):2204692. PubMed ID: 35942272
[TBL] [Abstract][Full Text] [Related]
9. Delivery and Expression of mRNA in the Secondary Lymphoid Organs Drive Immune Responses to Lipid Nanoparticle-mRNA Vaccines after Intramuscular Injection.
Takanashi A; Pouton CW; Al-Wassiti H
Mol Pharm; 2023 Aug; 20(8):3876-3885. PubMed ID: 37491979
[TBL] [Abstract][Full Text] [Related]
10. Comparison of DLin-MC3-DMA and ALC-0315 for siRNA Delivery to Hepatocytes and Hepatic Stellate Cells.
Ferraresso F; Strilchuk AW; Juang LJ; Poole LG; Luyendyk JP; Kastrup CJ
Mol Pharm; 2022 Jul; 19(7):2175-2182. PubMed ID: 35642083
[TBL] [Abstract][Full Text] [Related]
11. Flash nanoprecipitation assisted self-assembly of ionizable lipid nanoparticles for nucleic acid delivery.
Misra B; Hughes KA; Pentz WH; Samart P; Geldenhuys WJ; Bobbala S
Nanoscale; 2024 Apr; 16(14):6939-6948. PubMed ID: 38511623
[TBL] [Abstract][Full Text] [Related]
12. A fluorinated ionizable lipid improves the mRNA delivery efficiency of lipid nanoparticles.
Huo H; Cheng X; Xu J; Lin J; Chen N; Lu X
J Mater Chem B; 2023 May; 11(19):4171-4180. PubMed ID: 37129135
[TBL] [Abstract][Full Text] [Related]
13. Ionization and structural properties of mRNA lipid nanoparticles influence expression in intramuscular and intravascular administration.
Carrasco MJ; Alishetty S; Alameh MG; Said H; Wright L; Paige M; Soliman O; Weissman D; Cleveland TE; Grishaev A; Buschmann MD
Commun Biol; 2021 Aug; 4(1):956. PubMed ID: 34381159
[TBL] [Abstract][Full Text] [Related]
14. Nonclinical safety assessment of an mRNA Covid-19 vaccine candidate following repeated administrations and biodistribution.
Broudic K; Laurent S; Perkov V; Simon C; Garinot M; Truchot N; Latour J; Désert P
J Appl Toxicol; 2024 Mar; 44(3):371-390. PubMed ID: 37723625
[TBL] [Abstract][Full Text] [Related]
15. Adjuvant lipidoid-substituted lipid nanoparticles augment the immunogenicity of SARS-CoV-2 mRNA vaccines.
Han X; Alameh MG; Butowska K; Knox JJ; Lundgreen K; Ghattas M; Gong N; Xue L; Xu Y; Lavertu M; Bates P; Xu J; Nie G; Zhong Y; Weissman D; Mitchell MJ
Nat Nanotechnol; 2023 Sep; 18(9):1105-1114. PubMed ID: 37365276
[TBL] [Abstract][Full Text] [Related]
16. Rational design and combinatorial chemistry of ionizable lipids for RNA delivery.
Xu Y; Golubovic A; Xu S; Pan A; Li B
J Mater Chem B; 2023 Jul; 11(28):6527-6539. PubMed ID: 37345430
[TBL] [Abstract][Full Text] [Related]
17. Enhanced immunogenicity induced by mRNA vaccines with various lipid nanoparticles as carriers for SARS-CoV-2 infection.
Zhang Y; Wang J; Xing H; Liu C; Zha W; Dong S; Jiang Y; Li X
J Mater Chem B; 2023 Aug; 11(31):7454-7465. PubMed ID: 37448376
[TBL] [Abstract][Full Text] [Related]
18. Mechanistic Studies of an Automated Lipid Nanoparticle Reveal Critical Pharmaceutical Properties Associated with Enhanced mRNA Functional Delivery In Vitro and In Vivo.
Cui L; Hunter MR; Sonzini S; Pereira S; Romanelli SM; Liu K; Li W; Liang L; Yang B; Mahmoudi N; Desai AS
Small; 2022 Mar; 18(9):e2105832. PubMed ID: 34914866
[TBL] [Abstract][Full Text] [Related]
19. mRNA-lipid nanoparticle COVID-19 vaccines: Structure and stability.
Schoenmaker L; Witzigmann D; Kulkarni JA; Verbeke R; Kersten G; Jiskoot W; Crommelin DJA
Int J Pharm; 2021 May; 601():120586. PubMed ID: 33839230
[TBL] [Abstract][Full Text] [Related]
20. Iterative Design of Ionizable Lipids for Intramuscular mRNA Delivery.
Tilstra G; Couture-Senécal J; Lau YMA; Manning AM; Wong DSM; Janaeska WW; Wuraola TA; Pang J; Khan OF
J Am Chem Soc; 2023 Feb; 145(4):2294-2304. PubMed ID: 36652629
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]